Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report)’s stock price dropped 8.8% during trading on Friday. The company traded as low as $1.87 and last traded at $1.87. 8,135 shares changed hands during trading, an increase of 139% from the average daily volume of 3,405 shares. The stock had previously closed at $2.05.
Mayne Pharma Group Stock Performance
The firm has a 50 day moving average price of $2.22 and a two-hundred day moving average price of $1.90.
About Mayne Pharma Group
Mayne Pharma Group is an Australian specialty pharmaceutical company that develops, manufactures and commercializes branded, generic and specialty medicines. Its portfolio has included prescription products in areas such as women’s health, dermatology and oral and transdermal drug delivery.
The company has also provided pharmaceutical development and contract manufacturing services, supporting the formulation, production and commercialization of medicines for other pharmaceutical companies.
Further Reading
- Five stocks we like better than Mayne Pharma Group
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
